Skip to content

Drug interactions

Decitabine + Palifermin

Severity: Major

Decitabine and Palifermin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Palifermin promotes epithelial proliferation, potentially making mucosal cells more vulnerable to cytotoxic agents. Close timing with chemotherapy has been linked to more severe and longer oral mucositis.

What this interaction means in plain words

Decitabine and Palifermin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Decitabine belongs to Oncology; Palifermin belongs to Miscellaneous.

Evidence level: Moderate

Why it happens

Palifermin-induced epithelial proliferation increases mucosal susceptibility to cytotoxic chemotherapy.

What to do

Do not give palifermin within 24 hours before, during, or within 24 hours after decitabine. Monitor for mucositis.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Decitabine and Palifermin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Decitabine with Palifermin?

MediHelp rates the interaction as major. Decitabine and Palifermin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Palifermin promotes epithelial proliferation, potentially making mucosal cells more vulnerable to cytotoxic agents. Close timing with chemotherapy has been linked to more severe and longer oral mucositis.

How serious is the interaction between Decitabine and Palifermin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Do not give palifermin within 24 hours before, during, or within 24 hours after decitabine. Monitor for mucositis.

What other medicines interact with Decitabine?

MediHelp also lists interactions of Decitabine with, for example, Dengue vaccine, Etrasimod, Fingolimod. The full list is on the Decitabine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in